Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Philippe Paolantonacci is active.

Publication


Featured researches published by Philippe Paolantonacci.


Pda Journal of Pharmaceutical Science and Technology | 2018

Development of a premium Quality Plasma derived IVIg (IQYMUNE®) utilizing the principles of Quality by Design - A worked through case study

Philippe Paolantonacci; Philippe Appourchaux; Béatrice Claudel; Monique Ollivier; Richard Dennett; Laurent Siret

Polyvalent human normal immunoglobulins for intravenous use (IVIg), indicated for rare and often severe diseases, are complex plasma-derived protein preparations. A quality by design approach has been used to develop the Laboratoire Français du Fractionnement et des Biotechnologies new-generation IVIg, targeting a high level of purity to generate an enhanced safety profile while maintaining a high level of efficacy. A modular approach of quality by design was implemented consisting of five consecutive steps to cover all the stages from the product design to the final product control strategy. A well-defined target product profile was translated into 27 product quality attributes that formed the basis of the process design. In parallel, a product risk analysis was conducted and identified 19 critical quality attributes among the product quality attributes. Process risk analysis was carried out to establish the links between process parameters and critical quality attributes. Twelve critical steps were identified, and for each of these steps a risk mitigation plan was established. Among the different process risk mitigation exercises, five process robustness studies were conducted at qualified small scale with a design of experiment approach. For each process step, critical process parameters were identified and, for each critical process parameter, proven acceptable ranges were established. The quality risk management and risk mitigation outputs, including verification of proven acceptable ranges, were used to design the process verification exercise at industrial scale. Finally, the control strategy was established using a mix, or hybrid, of the traditional approach plus elements of the quality by design enhanced approach, as illustrated, to more robustly assign material and process controls and in order to securely meet product specifications. The advantages of this quality by design approach were improved process knowledge for industrial design and process validation and a clear justification of the process and product specifications as a basis for control strategy and future comparability exercises.


Archive | 2002

Method for preparing human immunoglobulin concentrates for therapeutic use

Abdessatar Chtourou; Philippe Paolantonacci; Roland Schmitthaeusler; Jacky Lirochon


Archive | 2006

Immunoglobulin G (IgG) concentrate depleted of anti-A and anti-B antibodies and of polyreactive IgGs

Abdessatar Chtourou; Frédéric Dhainaut; Philippe Paolantonacci


Archive | 2006

CONCENTRE D’IMMUNOGLOBULINES G (IgG) APPAUVRI EN ANTICORPS ANTI-A ET ANTI-B, ET EN IgG POLYREACTIVES

Abdessatar Chtourou; Frédéric Dhainaut; Philippe Paolantonacci


Archive | 2013

Matrice de chromatographie d'affinite

Philippe Paolantonacci; Abdessatar Chtourou


Archive | 2013

Matrice de chromatographie d'affinite a densite de ligands reduite

Philippe Paolantonacci; Abdessatar Chtourou


Archive | 2016

AFFINITY CHROMATOGRAPHY MATRIX

Philippe Paolantonacci; Abdessatar Chtourou


BioDrugs | 2017

Biological Safety of a Highly Purified 10% Liquid Intravenous Immunoglobulin Preparation from Human Plasma

Caroline Goussen; Steve Simoneau; Soline Bérend; Christine Jehan-Kimmel; Anne Bellon; Céline Ducloux; Bruno You; Philippe Paolantonacci; Monique Ollivier; Ludovic Burlot; Sami Chtourou; Benoit Flan


Archive | 2012

METHOD FOR PREPARING A DEPLETED PLASMA MATERIAL CONSISTING OF ONE OR MORE THROMBOGENIC FACTORS

Monique Ollivier; Philippe Paolantonacci


Archive | 2013

affinity chromatography matrix has reduced density of ligands

Philippe Paolantonacci; Abdessatar Chtourou

Collaboration


Dive into the Philippe Paolantonacci's collaboration.

Top Co-Authors

Avatar

Benoit Flan

Institut national de la recherche agronomique

View shared research outputs
Top Co-Authors

Avatar

Bruno You

Institut national de la recherche agronomique

View shared research outputs
Researchain Logo
Decentralizing Knowledge